BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 20434120)

  • 1. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria.
    Park YJ; Park SY; Oh EJ; Park JJ; Lee KY; Woo GJ; Lee K
    Diagn Microbiol Infect Dis; 2005 Apr; 51(4):265-9. PubMed ID: 15808318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production.
    Yang JL; Wang JT; Lauderdale TL; Chang SC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):310-6. PubMed ID: 19949754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Phoenix Automated Microbiology System for detecting extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescens.
    Park YJ; Yu JK; Lee S; Park JJ; Oh EJ
    Ann Clin Lab Sci; 2007; 37(1):75-8. PubMed ID: 17311873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression of AmpC and extended-spectrum beta-lactamases among clinical isolates of enterobacter cloacae and its impact on antibiotics susceptibility].
    She D; Liu Y
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1355-8. PubMed ID: 12509943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
    Ku YH; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of CTX-M-3 extended-spectrum beta-lactamase (ESBL) among cefotaxime-resistant Serratia marcescens at a medical center in middle Taiwan.
    Wu LT; Tsou MF; Wu HJ; Chen HE; Chuang YC; Yu WL
    Diagn Microbiol Infect Dis; 2004 Jun; 49(2):125-9. PubMed ID: 15183862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan.
    Yu WL; Cheng KC; Chi CJ; Chen HE; Chuang YC; Wu LT
    Clin Microbiol Infect; 2006 Jun; 12(6):579-82. PubMed ID: 16700709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
    Park YJ; Yu JK; Lee S; Oh EJ; Woo GJ
    J Antimicrob Chemother; 2007 Oct; 60(4):868-71. PubMed ID: 17660263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
    Wiegand I; Geiss HK; Mack D; Stürenburg E; Seifert H
    J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
    Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria.
    Apfalter P; Assadian O; Daxböck F; Hirschl AM; Rotter ML; Makristathis A
    J Antimicrob Chemother; 2007 May; 59(5):854-9. PubMed ID: 17347178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boronic acid disk tests for identification of extended-spectrum beta-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC beta-lactamases.
    Jeong SH; Song W; Park MJ; Kim JS; Kim HS; Bae IK; Lee KM
    Int J Antimicrob Agents; 2008 May; 31(5):467-71. PubMed ID: 18337065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control.
    Yu WL; Chuang YC; Walther-Rasmussen J
    J Microbiol Immunol Infect; 2006 Aug; 39(4):264-77. PubMed ID: 16926972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan.
    Cheng KC; Chuang YC; Wu LT; Huang GC; Yu WL
    Jpn J Infect Dis; 2006 Jun; 59(3):147-52. PubMed ID: 16785693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae.
    Szabó D; Bonomo RA; Silveira F; Pasculle AW; Baxter C; Linden PK; Hujer AM; Hujer KM; Deeley K; Paterson DL
    J Clin Microbiol; 2005 Oct; 43(10):5058-64. PubMed ID: 16207962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.